17(S)-HDHA is primarily recognized for its role in the resolution of inflammation and promoting tissue repair. It is a specialized pro-resolving mediator (SPM) derived from omega-3 fatty acids, particularly docosahexaenoic acid (DHA). This compound actively contributes to the termination of inflammatory responses by enhancing the clearance of cellular debris and pathogens, while also supporting the return of tissues to homeostasis. Its applications are particularly significant in medical research focused on chronic inflammatory diseases, such as arthritis, cardiovascular disorders, and neurodegenerative conditions. Additionally, 17(S)-HDHA is being explored for its potential in wound healing and tissue regeneration, making it a promising candidate for therapeutic development in regenerative medicine.